Somatostatin (SRIF) and growth hormone-releasing factor (GRF) are well characterized as hypothalamic neuropeptides which, respectively, inhibit and stimulate the secretion of growth hormone (GH). SRIF is also produced by pancreatic D cells and cells within the gut, where it can act to regulate pancreatic and gastrointestinal hormone secretion. A number of laboratories have demonstrated that the synthesis, receptors and endocrine activities of GRF and SRIF may be influenced by immune factors, such as the cytokines interleukin-1 (IL-1) (Scarborough et al. 1989, Lumpkin 1990, Campbell et al. 1991b, Honegger et al. 1991, Payne et al. 1992, Peisen et al. 1992, 1994), IL-2 (Karanth et al. 1992), IL-6 (Spangelo et al. 1989) and tumor necrosis factor-α (TNF-α) (Scarborough & Dinarello 1989, Walton & Cronin 1989, Gaillard et al. 1990, Elsasser et al. 1991) as well as lipopolysaccharide endotoxin (LPS), an inducer of cytokines (Kasting & Martin 1982, Yelich et al. 1993).
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 2 | 1 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
